Gilead Sciences Inc's Trading History
| ASMBAssembly Biosciences | May 27, 2026 | Ten Percent Owner | Uninformative Buy | 12.50M | $100.19M | |
| RCUSArcus Biosciences | Feb 20, 2025 | Ten Percent Owner | Informative Buy | 15.00M | $571.62M | |
| XLOXilio Therapeutics | Dec 19, 2024 | Ten Percent Owner | Informative Buy | 1.83M | $73.12M | |
| KYTXKyverna Therapeutics, Inc. | Feb 13, 2024 | Ten Percent Owner | Uninformative Buy | ― | $23.40M | |
| KLRSKalaris Therapeutics | Jun 28, 2023 | Ten Percent Owner | Informative Buy | 10.99M | $33.77M | |
| ~ACHNAchillion Pharmaceuticals | ― | ― | ― | $7.54M |
You May Also Like
Gilead Sciences Inc insider profile FAQ
What is the percentage of profitable transactions made by Gilead Sciences Inc?
The percentage of profitable transactions made by Gilead Sciences Inc is 22%.
What is the average return per transaction made by Gilead Sciences Inc?
The average return per transaction made by Gilead Sciences Inc is -12.00%.
What stocks does Gilead Sciences Inc hold?
Gilead Sciences Inc holds: ASMB, ~ACHN, RCUS, KLRS, XLO, KYTX stocks.
What was Gilead Sciences Inc’s latest transaction?
Gilead Sciences Inc’s latest transaction was an Uninformative Buy of $12.50M.
What was Gilead Sciences Inc's most profitable transaction?
Gilead Sciences Inc’s most profitable transaction was an Informative Buy of ASMB stock on December 23, 2024. The return on the trade was 119.30%.
What is Gilead Sciences Inc's role in Assembly Biosciences?
Gilead Sciences Inc's role in Assembly Biosciences is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.